OTCM
RMHB
Market cap1mUSD
Jul 09, Last price
0.00USD
1D
-18.00%
1Q
-10.87%
Jan 2017
-99.76%
IPO
-98.72%
Name
Rocky Mountain High Brands Inc
Chart & Performance
P/E
—
P/S
1.66
EPS
—
Div Yield, %
—
Shrs. gr., 5y
28.86%
Rev. gr., 5y
-8.86%
Revenues
721k
-45.68%
Net income
-29k
L
CFO
-480k
L-37.60%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rocky Mountain High Brands, Inc. (RMHB) operates as a lifestyle brand management enterprise, specializing in the development, manufacturing, promotion, and distribution of products enriched with hemp oil and hemp extract. The company’s comprehensive portfolio addresses diverse consumer needs across categories such as beverages, food items, fitness supplements, and skincare solutions. RMHB's extensive product line includes a variety of CBD-infused items like waters, gummies, concentrated liquids, tinctures, and capsules. They also provide topical applications such as triple relief salves and calming hemp lotions. Beyond their hemp-infused offerings, the company produces a range of other beverages, including naturally flavored citrus and mango energy drinks, a low-calorie coconut energy lime option, as well as lemonade and black tea. Their catalog further extends to hemp-infused energy shots in mango and mixed berry flavors, alongside premium high alkaline spring water. These goods are marketed under proprietary brand names such as Rocky Mountain High, HEMPd, HEMPFIT, Smarterita, Totally Hemp Crazy, Blue Leaf, Rock the Road Trip, Eagle Spirit, and Eagle Paa, in addition to various private label agreements. RMHB utilizes multiple sales channels, reaching customers through distributors, retailers, and direct online sales. Headquartered in Plano, Texas, the company officially changed its name to Rocky Mountain High Brands, Inc. in October 2014, having previously been known as Totally Hemp Crazy Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||